Suchergebnisse - "Peto, Richard"

PubPharm (10)

1

Body mass index and COVID-19 mortality : prospective study of 120 000 Mexican adults

enthalten in: International journal of epidemiology | 2022

von Alegre-Díaz, J. | Friedrichs, L. | Ramirez-Reyes, R. | +9

2

Remdesivir and three other drugs for hospitalised patients with COVID-19 : final results of the WHO Solidarity randomised trial and updated meta-analyses

enthalten in: Lancet (London, England) | 2022

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +98

CommentIn: Lancet. 2022 May 21;399(10339):1918-1920. - PMID 35512729

3

Considerations in boosting COVID-19 vaccine immune responses

enthalten in: Lancet (London, England) | 2021

von Krause, P. | Fleming, T. | Peto, R. | +15

CommentIn: Lancet. 2022 Mar 26;399(10331):1224. - PMID 35339219

4

SARS-CoV-2 Variants and Vaccines

enthalten in: The New England journal of medicine | 2021

von Krause, P. | Fleming, T. | Longini, I. | +18

5

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

enthalten in: The New England journal of medicine | 2021

von WHO Solidarity Trial Consortium | Pan, H. | Peto, R. | +172

CommentIn: N Engl J Med. 2021 Feb 11;384(6):576-577. - PMID 33264557

6

Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results

enthalten in: bioRxiv.org | 2021

von Pan, H. | Peto, R. | Karim, Q. | +12

7

Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them

enthalten in: The New England journal of medicine | 2021

von WHO Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation | Krause, P. | Fleming, T. | +18

CommentIn: Indian J Med Ethics. 2021 Apr-Jun;VI(2):1-7. - PMID 33908355

8

COVID-19 vaccine trials should seek worthwhile efficacy

enthalten in: Lancet (London, England) | 2020

von Krause, P. | Fleming, T. | Longini, I. | +18

9

Quality of primary health care in China : challenges and recommendations

enthalten in: Lancet (London, England) | 2020

von Li, X. | Krumholz, H. | Yip, W. | +29

CommentIn: Lancet. 2022 Jun 11;399(10342):2167. - PMID 35691305

10

Universal weekly testing as the UK COVID-19 lockdown exit strategy

enthalten in: Lancet (London, England) | 2020

von Peto, J. | Alwan, N. | Godfrey, K. | +32

1
[1]